Original Contributions |
From the Department of Molecular Cardiology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.
Correspondence to Subha Sen, PhD, DSc, Department of Molecular Cardiology/FF40, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail sens{at}ccsmtp.ccf.org
AbstractMyotrophin, a novel protein
that has been shown to stimulate myocyte growth, has been isolated,
purified, and sequenced from the hearts of spontaneously hypertensive
rats and dilated cardiomyopathic human tissue.
Recently, the cDNA clones encoding myotrophin have been isolated and
expressed in Escherichia coli, and the recombinant
myotrophin was found to be as biologically and immunologically active
as natural myotrophin. The mechanism by which myotrophin stimulates
protein synthesis and initiates myocardial hypertrophy is
not known. To evaluate the involvement of protein kinase C (PKC) in
myotrophin-induced hypertrophy, PKC activity and its
distribution in the subcellular fraction were determined in cultured
neonatal and adult myocytes. PKC activity was determined by measuring
the incorporation of 32P into histone type III-S and PKC
substrate peptide (
pep) from [
-32P]ATP
in neonatal myocytes. Myotrophin significantly stimulated PKC activity
in neonatal myocytes and was associated with a significant increase in
protein synthesis. The effect of myotrophin on the stimulation of PKC
activity and [3H]leucine incorporation was abolished by
pretreatment with either staurosporine or H-7, two
selective, pharmacological PKC inhibitors. Pretreatment of
myocytes with staurosporine also reduced the
myotrophin-induced mRNA levels of c-fos and ß-myosin
heavy chain. To evaluate the subcellular events whose occurrence was
due to myotrophin and translocation of PKC, we studied the effect of
genistein, a tyrosine kinase inhibitor, on
myotrophin-induced neonatal myocyte growth. Genistein attenuated the
[3H]leucine incorporation induced by myotrophin. To
define the specificity of the PKC isoform(s) involved in
myotrophin-stimulated myocyte growth, both neonatal and adult myocytes
were treated with myotrophin, and Western blot analyses were
performed by using the antibodies of different PKC isoforms. Results
showed that both PKC
and PKC
isoforms participated in the
myotrophin-induced neonatal myocyte growth, whereas only the PKC
isoform was involved in myotrophin-induced adult myocyte
hypertrophy. PKC
and PKC
do not seem to participate
in either neonatal or adult myocyte growth induced by myotrophin.
Treatment with antisense oligonucleotides specific for
PKC
and PKC
isoforms further supported this result. PKC
is the
major PKC isoform in neonatal myocytes and needs Ca2+ and
phospholipids for its activation, and PKC
(the
Ca2+-independent PKC isoform) is present in both
neonatal and adult myocytes; the 15-mer antisense
oligodeoxynucleotides of each were used for this study.
Treatment of neonatal myocytes with the PKC
and PKC
antisense
oligodeoxynucleotides for 5 days significantly reduced
Ca2+-dependent and Ca2+-independent PKC
activity, respectively, as well as the [3H]leucine
incorporation induced by myotrophin. Furthermore, myotrophin-induced
PKC activity was primarily located in the particulate fraction and did
not result in a concomitant decrease in the cytosolic fraction.
Myotrophin does not change PKC isoform expression (both
Ca2+ dependent and independent PKC isoforms used in this
study) in rat neonatal cardiac fibroblasts. Our data suggest that
myotrophin exerts its action on protein synthesis, possibly through a
tyrosine kinasecoupled pathway and translocation of PKC from the
cytosol to the cell membrane.
Key Words: myotrophin PKC ß-myosin heavy chain myocytes hypertrophy
This article has been cited by other articles:
![]() |
S. S. Palaniyandi, L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res, May 1, 2009; 82(2): 229 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Das, S. Gupta, A. Vasanji, Z. Xu, S. Misra, and S. Sen Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth: REGULATION BY MYOTROPHIN HAIRPIN LOOPS J. Biol. Chem., October 10, 2008; 283(41): 27947 - 27956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vary and C. J. Lynch Meal Feeding Stimulates Phosphorylation of Multiple Effector Proteins Regulating Protein Synthetic Processes in Rat Hearts J. Nutr., September 1, 2006; 136(9): 2284 - 2290. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarkar, M. Chawla-Sarkar, D. Young, K. Nishiyama, M. E. Rayborn, J. G. Hollyfield, and S. Sen Myocardial Cell Death and Regeneration during Progression of Cardiac Hypertrophy to Heart Failure J. Biol. Chem., December 10, 2004; 279(50): 52630 - 52642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarkar, E. Vellaichamy, D. Young, and S. Sen Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H107 - H117. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. G. Muller, N. L. Thakur, H. Ushijima, A. N. Thakur, A. Krasko, G. Le Pennec, M. M. Indap, S. Perovic-Ottstadt, H. C. Schroder, G. Lang, et al. Matrix-mediated canal formation in primmorphs from the sponge Suberites domuncula involves the expression of a CD36 receptor-ligand system J. Cell Sci., May 15, 2004; 117(12): 2579 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarkar, D. W. Leaman, S. Gupta, P. Sil, D. Young, A. Morehead, D. Mukherjee, N. Ratliff, Y. Sun, M. Rayborn, et al. Cardiac Overexpression of Myotrophin Triggers Myocardial Hypertrophy and Heart Failure in Transgenic Mice J. Biol. Chem., May 7, 2004; 279(19): 20422 - 20434. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. O'Brien, I. Loke, J. E. Davies, I. B. Squire, and L. L. Ng Myotrophin in human heart failure J. Am. Coll. Cardiol., August 20, 2003; 42(4): 719 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taoka, T. Ichimura, A. Wakamiya-Tsuruta, Y. Kubota, T. Araki, T. Obinata, and T. Isobe V-1, a Protein Expressed Transiently during Murine Cerebellar Development, Regulates Actin Polymerization via Interaction with Capping Protein J. Biol. Chem., February 14, 2003; 278(8): 5864 - 5870. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, N. H. Purcell, A. Lin, and S. Sen Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol., December 23, 2002; 159(6): 1019 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kerkela, M. Ilves, S. Pikkarainen, H. Tokola, J. Ronkainen, O. Vuolteenaho, J. Leppaluoto, and H. Ruskoaho Identification of PKCalpha Isoform-Specific Effects in Cardiac Myocytes Using Antisense Phosphorothioate Oligonucleotides Mol. Pharmacol., December 1, 2002; 62(6): 1482 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; 156(5): 905 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. SCHRÖDER, A. KRASKO, R. BATEL, A. SKOROKHOD, S. PAHLER, M. KRUSE, I. M. MÜLLER, and W. E. G. MÜLLER Stimulation of protein (collagen) synthesis in sponge cells by a cardiac myotrophin-related molecule from Suberites domuncula FASEB J, October 1, 2000; 14(13): 2022 - 2031. [Abstract] [Full Text] |
||||
![]() |
K. L. Butler, A. H. Huang, and J. K. Gwathmey AT1-receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2482 - H2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; 156(5): 905 - 919. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |